Holen Sie sich die Stockscreener-App
7.89
1.13%
-0.09
Handel nachbörslich:
8.00
0.11
+1.39%
Amicus Therapeutics Inc Aktie (FOLD) Neueste Nachrichten
166,491 Shares in Amicus Therapeutics, Inc. $FOLD Acquired by Banque Transatlantique SA - MarketBeat
Cubist Systematic Strategies LLC Takes $4.51 Million Position in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Amicus Therapeutics Presents Long-Term Efficacy Data for Cipaglucosidase Alfa and Miglustat in Late-Onset Pompe Disease at ICIEM 2025 - Quiver Quantitative
New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEM - GlobeNewswire
Breakthrough 4-Year Results: Amicus Pompe Disease Treatment Maintains Muscle Function in Long-term Study - Stock Titan
Amicus Therapeutics, Inc. $FOLD Shares Sold by Parkman Healthcare Partners LLC - MarketBeat
Vestal Point Capital LP Grows Stake in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Dark Forest Capital Management LP Raises Stake in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Palo Alto Investors LP Sells 317,477 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
Amicus Therapeutics, Inc. $FOLD Stock Holdings Decreased by Trexquant Investment LP - MarketBeat
683 Capital Management LLC Acquires New Holdings in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Amicus Therapeutics, Inc. $FOLD is Redmile Group LLC's 3rd Largest Position - MarketBeat
PDT Partners LLC Buys 388,817 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
Rafferty Asset Management LLC Trims Stock Position in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Can Amicus Therapeutics Inc. outperform under higher oil pricesPrice Action & Expert-Curated Trade Recommendations - خودرو بانک
Ranking Amicus Therapeutics Inc. among high performing stocks via toolsWeekly Investment Recap & Advanced Technical Signal Analysis - Newser
What analysts say about Amicus Therapeutics Inc. stockWeekly Profit Recap & Verified Chart Pattern Trade Signals - خودرو بانک
Is Amicus Therapeutics Inc. a candidate for recovery playPortfolio Return Summary & AI Driven Stock Reports - Newser
Can a trend reversal in Amicus Therapeutics Inc. lead to recoveryJuly 2025 Update & Safe Capital Allocation Plans - Newser
Amicus Therapeutics Inc. stock momentum explained2025 Market Sentiment & Growth Focused Investment Plans - Newser
How to read the order book for Amicus Therapeutics Inc.2025 Stock Rankings & Daily Market Momentum Tracking - Newser
Is this a good reentry point in Amicus Therapeutics Inc.July 2025 Final Week & High Accuracy Trade Signal Alerts - Newser
Using economic indicators to assess Amicus Therapeutics Inc. potentialJuly 2025 Recap & Pattern Based Trade Signal System - Newser
Evaluating Amicus Therapeutics Inc. with trendline analysisMarket Performance Recap & Reliable Price Breakout Alerts - Newser
Is Amicus Therapeutics Inc. reversing from oversold territory2025 Macro Impact & Verified Momentum Watchlists - Newser
Quantitative breakdown of Amicus Therapeutics Inc. recent moveMarket Rally & Scalable Portfolio Growth Methods - Newser
Kodai Capital Management LP Purchases New Stake in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Using AI based signals to follow Amicus Therapeutics Inc.Portfolio Performance Report & AI Forecasted Entry/Exit Points - Newser
Wall Street Zen Downgrades Amicus Therapeutics (NASDAQ:FOLD) to Hold - MarketBeat
Should you hold or exit Amicus Therapeutics Inc. now2025 Volatility Report & Short-Term Trading Alerts - Newser
Russell Investments Group Ltd. Increases Stock Holdings in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Real time social sentiment graph for Amicus Therapeutics Inc.2025 Macro Impact & Safe Entry Momentum Stock Tips - Newser
Reversal indicators forming on Amicus Therapeutics Inc. stockJuly 2025 Drop Watch & Reliable Price Breakout Alerts - Newser
Using Python tools to backtest Amicus Therapeutics Inc. strategiesCEO Change & Reliable Price Action Trade Plans - Newser
Earnings visualization tools for Amicus Therapeutics Inc.2025 AllTime Highs & Verified Short-Term Plans - Newser
How to build a custom watchlist for Amicus Therapeutics Inc.2025 Retail Activity & Free Weekly Chart Analysis and Trade Guides - Newser
Applying Wyckoff theory to Amicus Therapeutics Inc. stockJuly 2025 Levels & Safe Capital Investment Plans - Newser
Is Amicus Therapeutics Inc. stock a buy or sell getLinesFromResByArray error: size == 0 - 머스트 뉴스
Has Amicus Therapeutics Inc. found a price floorMarket Risk Analysis & Low Risk High Reward Trade Ideas - Newser
What makes Amicus Therapeutics Inc. stock price move sharplyJuly 2025 Intraday Action & Precise Entry and Exit Recommendations - Newser
Analyzing Amicus Therapeutics Inc. with risk reward ratio chartsWeekly Market Outlook & Target Return Focused Stock Picks - Newser
Price Channel Expanding on Amicus Therapeutics Inc.’s Chart getLinesFromResByArray error: size == 0 - thegnnews.com
1.96%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):